Company intelligence / Profile preview
MV BioTherapeutics
Schlieren, Zurich, Switzerlandmv-biotherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
MV BioTherapeutics is a Swiss clinical-stage biotechnology company focused on developing innovative Live Biotherapeutic Products (LBPs) for oncology and infectious diseases. The company's proprietary MV-Vax platform utilizes non-genetically modified bacteria to induce potent mucosal and systemic immune responses. Their lead candidate is being developed for the treatment of non-muscle invasive bladder cancer as a potentially safer and more effective alternative to current standard-of-care treatments like BCG. Additionally, the company has advanced a mucosal vaccine candidate for COVID-19 into early clinical testing. MV BioTherapeutics aims to revolutionize immunotherapy by leveraging the natural symbiotic relationship between microbes and the human immune system.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Live biotherapeutic product therapyVaccineMicrobial therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on MV BioTherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MV BioTherapeutics.